MannKind (MNKD)
(Real Time Quote from BATS)
$4.90 USD
-0.14 (-2.78%)
Updated Jun 14, 2024 09:44 AM ET
3-Hold of 5 3
D Value A Growth D Momentum B VGM
Brokerage Reports
MannKind Corporation [MNKD]
Reports for Purchase
Showing records 141 - 160 ( 228 total )
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Transferring Coverage: Take a Deep Breath - AFFINITY Expected Mid-August
Provider: BRINSON PATRICK SECURITIES CORPORATION
Analyst: BERNARDINO V
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
A Threat of Competition Spooked Investors Yesterday
Provider: Griffin Securities, Inc.
Analyst: MARKEY K
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
We reiterate our BUY recommendation with a target price of $11.00 per share.
Provider: Griffin Securities, Inc.
Analyst: MARKEY K
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Take A Deep Breath... Afrezza Results Are Coming Up Quickly
Provider: BRINSON PATRICK SECURITIES CORPORATION
Analyst: HIGGINS M
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Financials in-line; No changes to Afrezza timeline; We see CV risk as limited.
Provider: BRINSON PATRICK SECURITIES CORPORATION
Analyst: HIGGINS M
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
INITIATION: Take Advantage Of The Turbulence!
Provider: BRINSON PATRICK SECURITIES CORPORATION
Analyst: HIGGINS M
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Griffin Securities Updates Coverage on MannKind Corp. (MNKD)
Provider: GRIFFIN SECURITIES, INC.
Analyst: MARKEY K
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Griffin Securities Updates Coverage on MannKind Corp. (MNKD)
Provider: GRIFFIN SECURITIES, INC.
Analyst: MARKEY K
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Reports 2Q12 Results and Updates Timeline for Afrezza Pivotal Studies
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Reports 2Q12 Results and Updates Timeline for Afrezza Pivotal Studies
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M